Enovis to Host Third Quarter 2026 Results Conference Call on November 5thGlobeNewsWire · Oct 8, 2026
electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head ComparisonDefense World · Oct 6, 2026
Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL)Defense World · Oct 6, 2026
Enovis becomes first multi-registry industry sponsor of AAOS Registry ProgramPRNewsWire · Sep 22, 2026
Enovis (NYSE:ENOV) Hits New 52-Week Low – What’s Next?Defense World · Sep 16, 2026
Insider at Medical Device Maker Buys More Than 7,500 SharesFool - Investing News · Sep 14, 2026Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | $0.85 | $0.90 | Beat |
| May 7, 2026 | $0.82 | $0.89 | Beat |
| Feb 26, 2026 | $0.81 | $0.95 | Beat |
| Nov 6, 2025 | $0.67 | $0.75 | Beat |
| Aug 7, 2025 | $0.74 | $0.79 | Beat |
| May 8, 2025 | $0.74 | $0.81 | Beat |